Reid Hoffman, co-founder of LinkedIn, has initiated a new venture, Manas AI, aimed at transforming cancer drug development through artificial intelligence. Alongside Dr. Siddhartha Mukherjee, Hoffman seeks to enhance the speed and efficiency of drug discovery by uniting research expertise with AI technology. Initially targeting aggressive cancers like breast and prostate cancer, Manas has already secured $24.6 million in seed funding and will operate its systems in Microsoft data centers, demonstrating a commitment to making a significant impact on cancer treatment and the pharmaceutical landscape.
"Most people have had friends, family members, etc., who've died from cancer or had serious cancer problems. If we can make a huge difference on this, and this is the kind of thing that AI can make a huge difference in, it's the kind of reason why AI can be great for humanity."
"Manas is bringing AI to some of the world's top drug development scientists to deepen their expertise and speed up the rate at which new drugs are discovered."
Collection
[
|
...
]